Investment and Corporate Finance Marketplace signs strategic partnership with leading US Investment Healthcare Platform

London, UK, July 8th , 2020: ReachX, a leading financial platform re-inventing access to Investment Banking services, is pleased to announce the signing of a partnership with US based AngelMD Inc.

AngelMD has thousands of physicians, dentists, hospital executives and other industry experts who source, evaluate and advise companies on the AngelMD platform. While the company originated in the US, membership and deal flow is increasingly international. The expert network not only helps curate the deal flow, it serves the critical role of lending post investment advisory support. The AngelMD platform is designed to identify the most promising technologies and match them with investors who want healthcare sector exposure.

As part of the exclusive investment banking partnership for the UK and EU, ReachX will share highly curated investment opportunities in innovative medical devices, therapeutics and digital health from the AngelMD network with ReachX’s Institutional clients. The partnership will expand ReachX Deal Origination service in the Healthcare space. AngelMD will be providing insights and advisors to support ReachX institutional investors including, family offices, private equity firms and wealth managers.

At present, ReachX professionals include top rated analysts, economists, researchers, corporate finance, capital markets and investor relations specialists, who provide advice and insight without conflict of interest for financial firms and corporations via the company’s digital platform. The marketplace also recently launched its Deal Origination Platform which attracted more than $150M investment opportunities since Q1 2020.

ReachX was founded in December 2017 by Rafael S. Lajeunesse and Olivier Beau de Loménie. The idea was born out of creating an unbiased research, information and services hub fit for a post-MiFID II operating environment.

Commenting on the signing of the partnership, Rafael S. Lajeunesse, CEO of ReachX, said: “We are very pleased to partner with the AngelMD team, which brings proprietary opportunities in the healthcare space. The current context will increase the interest in healthcare for years to come and we want to ensure our investors have access to the best opportunities in the space ” and Bob Velez, Head of Investor Relations at AngelMD mentioned: “ReachX is an innovative, FCA regulated platform and is exactly the type of partner we like to work with. They are providing tremendous value to their clients through the use of technology in a traditionally analog environment.”

For enquiries contact:

Info@ReachX.co

About ReachX

ReachX is a post-MiFID II company headquartered in London, UK. The company is working to transform traditional financial market research and investment banking services via its global curated platform of market professionals. ReachX is fully MiFID II compliant with complete transparency on costs and services with no inducements, trading or transactions involved. Effective September 2018, the company is authorised and regulated by the Financial Conduct Authority (Services Register number is 811226). For general enquiries, please email us at: info@reachx.co

Follow ReachX:

London Stock Exchange Marketplace: https://www.lsegissuerservices.com/marketplace/reachx

LinkedIn: https://www.linkedin.com/company/reachxltd.

Twitter: @ReachxInfo

YouTube Channel: https://www.youtube.com/channel/UCxJgz9TVCgqRY-bruo21qzw

SoundCloud Hub: https://soundcloud.com/user-626820285

About AngelMD

AngelMD -- an online Healthcare Investment and Innovation Marketplace -- connects and engages a network of healthcare providers and subject matter experts, angel and institutional investors and private healthcare companies through a technology platform to create better outcomes for investors, entrepreneurs and patients. For more information, visit https://www.angelmd.co


Attached Media


About ReachX Limited

About ReachX ReachX is a post-MiFID II company headquartered in London, UK. The company is working to transform traditional financial market research and investment banking services via its global curated platform of experts. ReachX is fully MiFID II compliant with complete transparency on costs and services with no inducements, trading or transactions involved. The company is authorised and regulated by the Financial Conduct Authority (number is 811226). For general enquiries, please email us at: info@reachx.co


Press Contacts